Bloomberg News reporter Emma Court explains how these so-called "miracle" weight loss drugs work, and discusses side effects, long-term impacts, and what it all means for the body positivity movement. Also, John Powers reviews Michelle Yeoh's Netflix comedy-thriller series The Brothers Sun. Learn more about sponsor message choices: podcastchoices.com/adchoices NPR Privacy Policy
On the TED radio hour, linguist Ann Curzan says she gets a lot of complaints about people using the pronoun they to refer to one person.
I sometimes get into arguments with people where they will say to me, but.
It can't be singular.
And I will say, but it is.
The history behind words causing a lot of debate.
That's on the Ted radio hour from NPR.
This is FRESH AIR.
I'm Tanya Moseley.
Looking to get back in your type two diabetes zone once weekly, Ozempic can help.
Ozempic.
No doubt you've seen this commercial for Ozempic, or maybe you've heard about the shortages or that Oprah and Elon Musk are using a new class of drugs like Ozempic to lose weight, or maybe you're on them yourself.
Ozempic, which is the brand name for semaglutide, is an injectable prescription originally used to treat type two diabetes.
But over the last few years and other drugs that are classified as GLP one s have also revolutionized the treatment for obesity.
With roughly two out of three adults in America classified as overweight or obese, these drugs now have people talking about weight loss in new ways.
Even Weight Watchers now offers prescriptions of these drugs to help lose weight.
And researchers are looking into how they might help with other conditions like heart disease and addiction and polycystic ovary syndrome, Parkinson's, and even some cancers.
But there's still a lot of research to be done.
And meanwhile, the prospect of finding a cure for obesity has thrown the demand into overdrive.
With shortages all over the world widening the divide on who has access and who can pay out of pocket for drugs that most insurance companies don't cover for weight loss.
Emma court has been reporting on ozempic and this new class of weight loss drugs for Bloomberg.